Fox Chase Cancer Center’s Post

Stay tuned for a discussion on lung cancer data presented at American Society of Clinical Oncology (ASCO) 2024 - Narjust Florez M.D. Stephen Liu International Association for the Study of Lung Cancer #ASCO24 #ASCO #Cancer #LCSM #OncoDaily #Oncology

It's time to integrate evidence-based FCR interventions into existing guidelines to enhance survivorship and alleviate silent suffering - Cristiane Bergerot Daniel Hall American Cancer Society Journals #Cancer #EvidenceBasedMedicine #OncoDaily #Oncology #CancerSurvivorship #CancerSupport

The landscape of breast cancer screening is evolving. According to the latest update from the US Preventive Services Task Force, the recommended screening age for breast cancer has been revised from age 50 to age 40 for the average risk patient. Stay informed about these crucial changes and their impact on early detection efforts. Check out this article for more details on the latest advancements in breast cancer research and how they intersect with screening guidelines: https://lnkd.in/eEmu4BNu

Looking forward to co-chairing Strategies for Detecting MRD and How to Apply It in the Clinic - AACR24 session with AACR President, Philip D. Greenberg - Lynn M. Schuchter American Association for Cancer Research #AACR24 #ClinicalOncology #ASCO #Cancer #MRD #OncoDaily #Oncology

Key role of immunotherapy in Breast Cancer

🎉 As you all know, last week we launched our second-year newsletter, highlighting our key achievements in revolutionising breast cancer treatment 🎗 We’re excited to share our progress, including the launch of an international study on our AI-driven radiomics tools 🧠 👉 For additional insights, don’t forget to check out our article on the website: https://lnkd.in/dpYT2NXv #HorizonEU #EUFunded #BreastCancer #Newsletter

The #NCI Cancer Research Data Commons is a multi-year program of building cancer data repositories of all shapes, sizes, and data types. It has been a privilege to have contributed to it and its predecessors for the last 14 years. #cancerresearch #bigdata

I had an illuminating chat recently with Charlotte Coles, Professor of Breast Cancer Clinical Oncology at the University of Cambridge, UK. She chaired The Lancet’s Breast Cancer Commission released this week, which highlights global breast cancer inequities and presents a roadmap to tackle these urgent challenges.   It’s an honour to have this one-to-one time with experts, especially when they are brilliant and down-to-earth like Prof Coles.   Several points she made stood out for me:   “There are a lot of current misconceptions that breast cancer is solved, and it isn't.” “Often, you see a piece on breast cancer and 95% is focused on curing early breast cancer…we talk a lot about the challenges around metastatic breast cancer but have a really positive outlook about the future. We hope to be able to cure some people with metastatic breast cancer, which has been thought to be impossible in the past. But we want to make sure that we alleviate suffering for all, and don't abandon anyone. It's about changing the whole mindset” around metastatic breast cancer. “Prevention is incredibly important”. But “it has to be a united policy change because in terms of prevention, it's very much been directed at individuals, which you could see almost like blame...But if you actually link it with policy, then that makes it much easier for those individuals to be able to modify their lives”. For breast cancer clinicians, Coles hopes the Commission can inform and galvanise them to “realise what's happening globally. Let's not be complacent and let's try and think about what we can do. But rather than as individual health-care practitioners, what we can actually do as a body, and how much further we can go if we work together”.   https://lnkd.in/eps3iiCN   #breastcancer #metastaticbreastcancer #inequity #globalhealth #lancet

Take a moment to read our great blog post!!!

The April American Society of Clinical Oncology (ASCO) Plenary Series are here - Toni Choueiri https://lnkd.in/gwGsFvc3 #oncodaily #oncology #cancer #research #ASCO #ASCOPlenarySeries